Related Experiment Videos
Experimental murine amyloidosis: experience with Candida albicans as an amyloidogenic agent and liver biopsy as a
Abstract:
We describe a method of inducing experimental amyloidosis in mice using injections of Candida albicans. Both viable and non-viable Candida produced amyloid and we compare the results with each method. Diagnosis was by liver biopsy, a technique of value in assessing the natural history of the disease. Once the amyloid had been induced, the disease always progressed until the animals died of generalised amyloidosis. This experimental model should, therefore, be suitable to use in assessing the treatment of amyloidosis.
Insights
Researchers developed a new method to induce experimental amyloidosis in mice using Candida albicans injections. This model, confirmed by liver biopsy, shows disease progression and is suitable for testing amyloidosis treatments.
Area of Science:
- Immunology
- Pathology
- Microbiology
Background:
- Amyloidosis is a group of diseases characterized by the deposition of amyloid proteins in various organs.
- Current experimental models for amyloidosis have limitations in mimicking the natural progression of the disease.
- Candida albicans, a common fungus, has been implicated in inflammatory processes, suggesting a potential role in amyloid formation.
Purpose of the Study:
- To establish a novel experimental model for inducing amyloidosis in mice.
- To investigate the efficacy of Candida albicans in inducing amyloidosis.
- To compare the effects of viable versus non-viable Candida albicans on amyloid deposition.
Main Methods:
- Induction of experimental amyloidosis in mice via intravenous injections of Candida albicans (both viable and non-viable strains).
- Diagnosis and assessment of amyloid deposition through liver biopsy.
- Monitoring disease progression and survival rates of the experimental animals.
Main Results:
- Successful induction of generalized amyloidosis in mice using Candida albicans injections.
- Both viable and non-viable Candida albicans were effective in inducing amyloid formation.
- Liver biopsy proved to be a valuable diagnostic tool for assessing the disease.
- Induced amyloidosis consistently progressed to a fatal outcome in the experimental animals.
Conclusions:
- A reliable experimental model for inducing amyloidosis in mice has been established using Candida albicans.
- This model demonstrates consistent disease progression, making it suitable for evaluating potential therapeutic interventions for amyloidosis.
- Further research can utilize this model to assess the efficacy of various treatments for generalized amyloidosis.